My Account | Shopping Cart | Contact  
Trilink Biotech Logo

Oligonucleotides | mRNA & Long RNA | Nucleotides | CleanCap® | CleanTag® | CleanAmp® | Custom Chemistry | cGMP


20th Anniversary
Contact Us
Meet the Team
Signature Quality
Corporate Responsibility
Legal Notices

Research Collaborations

TriLink is always seeking collaborative relationships where TriLink is an active participant in certain aspects of your research program. We have a research department with broad chemical and oligonucleotide experience. Please contact us to discuss your proposal.

Current and Previous Collaborations
  • 2015
    • Dr. Yizhou Dong; The Ohio State University
      Novel mRNA Therapeutics for Genetic Disorder
  • 2014
    • Dr. LinLin Zhao; Central Michigan University
      Interactions of Oxidative DNA Damage with DNA Polymerases
  • 2013
    • Dr. James Cole; University of Connecticut
      Mapping the ss-dsDNA PKR Binding Site
    • Dr. Aaron Leconte; W.M. Keck Science Department, Claremont Colleges
      Discovery and Characterization of New Mutant DNA Polymerase - Modified Substrate Interactions
  • 2012
    • Dr. Tony Yan; Brock University
      Regulation of Nucleic Acid Hybridization and Binding by Azobenzene Analogues
  • 2011
    • Dr. Rebecca Bellone; University of Tampa
      Genetic Investigation of "Tiger Eye" in the Pure Puerto Rican Paso Fino Horse
    • Dr. David Gorin; Smith College
      Selectivity in Complex Contexts: Targeting Chemical Reactions with DNA-Small Molecule Conjugates
    • Dr. Rahul Kohli; University of Pennsylvania
      Pro-mutagenic Polymerases Involved in Drug Resistance
  • 2010
    • Dr. Mary Lai Preuss; Webster University
      Map-Based Cloning of Arabidopsis Root Hair Developmental Mutants
    • Dr. Linda Chelico; University of Saskatchewan
      Oligonucleotides for Exploring the Replication of the Retrovirus HIV
  • 2009
    • Dr. Christopher Wilds; Concordia University
      DNA Repair Studies of CrossLinked DNA with O(6)-alkylguanini-DNA alkyltransferase (AGT)
    • Dr. John Owen; Wake Forest University
      Quantitative Assessment of the V617F Mutation in Myeloproliferative Diseases
    • Debbie Tahmassebi; University of San Diego
      To Elucidate the Dynamic Conformational Changes Associated with the Synthesis Mode of DNA Polymerase Using Florescence Spectroscopic Techniques
  • 2008
    • Dr. Isabelle Barrette-Ng; University of Calgary
      CleanAmp™ Primers for Detecting Genetically Modified Organisms
    • Dr. Bin Wang; Marshall University
      CleanAmp™ Primers for Detection of mRNA Expression Levels in Antioxidant - Treated Rats
    • Dr. Bradley Miller; University of Virginia
      Single-Cell Mitochondrial DNA Mutation Detection
    • Dr. Isabelle Barrette-Ng; University of Calgary
      CleanAmp™ Primers for detecting genetically modified organisms
    • Dr. Yi-Wei Tang; Vanderbilt University Hospital
      Enhance Herpesviruses Detection in Cerebrospinal Fluid by a Multiplex PCR
    • Dr. Shu Chen; University of Guelph
      CleanAmp™ Primers for Detection of Probiotic Bacterial in Fecal Samples
    • Dr. Kenneth Ng; University of Calgary
      Nucleoside Triphosphate Analogues as Inhibitors of Viral Polymerases
  • 2007
    • Dr. Lisa Johansen; University of Colorado Denver
      Oligonucleotides for Exploring Functional Genomics
    • Dr. Elizabeth Jamieson; Smith College
      Oligonucleotides for Thermodynamic Studies
    • Dr. Dong Wang; Stanford University
      Structural basis of regulation of RNA polymerase II transcription elongation
    • Dr. Stephanie Schroeder; Webster University
      PCR Primer Design for Undergraduate Teaching and Research
  • 2006
    • Dr. Anne Noronha; Concordia University
      Ability of the E. coli repair protein, Ada C, to correct the DNA alkylation product of the leukemia drug, hepsulfam.
    • Dr. Gayathri Devi; Duke University
      Targeting Epidermal Growth Factor Receptor (ErbB2) in Inflammatory Breast Cancer Therapy
    • Dr. Etienne Leygue and Jimin Guo; University of Manitoba
      Modulation of Estrogen Receptor Mediated Transcription by Targeting of the Steroid RNA Receptor
  • 2005
    • Dr. Malte Beringer; University of Witten/Herdecke
      Elucidation of the Mechanism of Ribosome Activity
    • Dr. Daniel Herschlag; Stanford University
      Solving RNA Folds at Nucleotide Resolution with Multiplexed Radical Resources
    • Dr. Rebecca Bellone; University of Tampa
      Studies Regarding Gene Linkages in Appaloosa Horses
    • Dr. John L. McKillip; Ball State University
      Real-time Assessment of Regulator and Virulence Gene Expression in Food Pathogens Using Molecular Beacon NASBA
    • Dr. Gordon Lutz; Drexel University
  • 2004
    • Dr. Jennifer Myka; Thomas Moore University / Brescia University
      PCR Primer Design for Undergraduate Teaching and Research
    • Dr. Stephanie Schroeder; Webster University
      PCR Primer Design for Undergraduate Teaching and Research
    • Dr. Richard Showman; University of South Carolina
      Ribonucleoside Analog Disruption of Mitochondrial Function in Human Blood Borne Pathogens
  • 2003
    • Dr. Rebecca Terry; University of Tampa
    • Peter Strazewski; Universite Claude Bernard Lyon
  • 2002
    • Dr. Zucai Suo; Ohio State University
      Kinetic, Dynamic, and Structure-Function Relationship Studies of a DNA Lesion Bypass Polymerase Dpo4
    • Dr. Timothy Koh; University of Illinois at Chicago
      Role of Small Heat Shock Proteins in Muscle Injury
    • Dr. Robert Striker; University of Wisconsin-Madison
      Nucleotide Selectivity of Error Prone RNA Viral Polymerases

Licensing Your Compound  
TriLink is committed to offering its customers a wide variety of nucleosides, linkers, spacers and reagents that are valuable in the synthesis of oligonucleotides. If you have compounds useful for oligonucleotide synthesis, we would be happy to consider licensing your compound.

If you have developed a new nucleoside analog, or other compound useful for oligonucleotide synthesis, we'd like to hear about it!!

Commercializing your compound through TriLink:

  • will keep you from being overwhelmed by orders and inquiries.
  • allows its use to be explored in a variety of research applications.
  • helps you to recoup your investment.

Contact us today to discuss licensing opportunities.


  Twitter Twitter Facebook Facebook Linked In Linked In RSS RSS Google RSS  
© 2019 TriLink BioTechnologies, LLC | All Rights Reserved